Kayne Anderson Rudnick Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.47K Hold
13
﹤0.01% 756
2025
Q4
$3.26K Hold
13
﹤0.01% 777
2025
Q3
$3.73K Hold
13
﹤0.01% 774
2025
Q2
$3.41K Buy
13
+2
+18% +$487 ﹤0.01% 787
2025
Q1
$2.56K Hold
11
﹤0.01% 781
2024
Q4
$2.52K Hold
11
﹤0.01% 797
2024
Q3
$2.46K Hold
11
﹤0.01% 794
2024
Q2
$2.24K Sell
11
-1
-8% -$203 ﹤0.01% 770
2024
Q1
$2.62K Hold
12
﹤0.01% 739
2023
Q4
$2.73K Buy
12
+3
+33% +$630 ﹤0.01% 723
2023
Q3
$1.81K Sell
9
-1
-10% -$211 ﹤0.01% 692
2023
Q2
$2.17K Buy
10
+1
+11% +$194 ﹤0.01% 678
2023
Q1
$1.83K Hold
9
﹤0.01% 628
2022
Q4
$1.88K Hold
9
﹤0.01% 643
2022
Q3
$2K Hold
9
﹤0.01% 613
2022
Q2
$2K Sell
9
-117
-93% -$24.9K ﹤0.01% 580
2022
Q1
$28K Hold
126
﹤0.01% 489
2021
Q4
$34K Hold
126
﹤0.01% 488
2021
Q3
$30K Hold
126
﹤0.01% 491
2021
Q2
$30K Hold
126
﹤0.01% 492
2021
Q1
$28K Buy
126
+117
+1,300% +$23.5K ﹤0.01% 487
2020
Q4
$2K Hold
9
﹤0.01% 543
2020
Q3
$2K Hold
9
﹤0.01% 505
2020
Q2
$1K Hold
9
﹤0.01% 530
2020
Q1
$1K Hold
9
﹤0.01% 584
2019
Q4
$1K Buy
+9
New +$1.3K ﹤0.01% 624

Other funds holding LH

Kayne Anderson Rudnick Investment Management's LH Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management held its Labcorp (LH) position steady in Q1 2026 at 13 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Kayne Anderson Rudnick Investment Management first reported a position in LH in Q4 2019 and has held it in 26 quarters since. The position peaked at $34K in Q4 2021. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 13 shares of Labcorp worth $3.47K as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #756 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Labcorp in Q4 2019 and has held it in 26 quarters since.
  • Kayne Anderson Rudnick Investment Management's Labcorp position peaked at $34K in Q4 2021.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.